Evidence map›Paper›PMID 40647404›Full record

ReviewCancers2025

Current Approaches of Nuclear Molecular Imaging in Breast Cancer.

Laura Schäfer, Betül Altunay, Amelie Heesch, Thiemo van Nijnatten, Sofia Vaz, Malik Eid Juweid, Felix Manuel Mottaghy

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Per-patient Comparison of [Journal of Cancer · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura SchäferDepartment of Nuclear Medicine, University Hospital RWTH Aachen, 52074 Aachen, Germany.ORCID 0009-0004-8198-5215
Betül AltunayDepartment of Nuclear Medicine, University Hospital RWTH Aachen, 52074 Aachen, Germany.ORCID 0000-0003-2566-5394
Amelie HeeschDepartment of Nuclear Medicine, University Hospital RWTH Aachen, 52074 Aachen, Germany.
Thiemo van NijnattenDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), 6229 HX Maastricht, The Netherlands.
Sofia VazNuclear Medicine-Radiopharmacology, Champalimaud Clinical Center, Champalimaud Foundation, 1400-038 Lisbon, Portugal.
Malik Eid JuweidDepartment of Radiology and Nuclear Medicine, University of Jordan, Amman 11942, Jordan.ORCID 0000-0002-6294-8118
Felix Manuel MottaghyDepartment of Nuclear Medicine, University Hospital RWTH Aachen, 52074 Aachen, Germany.ORCID 0000-0002-7212-6521

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this narrative review, we aim to summarize recent advancements in nuclear molecular imaging techniques and their applications in BCa management. The main focus of this review is on the most relevant clinical investigations from the past 2-3 years that highlight the enhanced diagnostic and therapeutic value of these imaging modalities. A variety of radiolabeled probes introduced in molecular imaging is explored, detailing their roles in the accurate diagnosis and characterization of BCa, as well as their integration into radioligand therapy and theragnostic strategies.

Indexed as

breast cancermolecular imagingPETprecision medicineprediction

Identifiers

PMID40647404
PMCPMC12249193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.